Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

15.080
+0.0500.33%
Volume:954.63K
Turnover:14.38M
Market Cap:47.06B
PE:5.62
High:15.150
Open:15.050
Low:14.990
Close:15.030
52wk High:21.258
52wk Low:14.910
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:2.13
T/O Rate:0.07%
Dividend:0.79
Dividend Rate:5.24%
EPS(LYR):2.683
ROE:8.04%
ROA:2.56%
PB:0.47
PE(LYR):5.62
PS:0.07

Loading ...

SINOPHARM Receives Additional Investment from Lazard Asset Management LLC Involving 2.1 Million Shares

Deep News
·
Mar 30

A Look At Sinopharm Group (SEHK:1099) Valuation After The Proposed 2025 Final Dividend Announcement

Simply Wall St.
·
Mar 28

SINOPHARM Establishes New Subsidiary in Xiong'an

Deep News
·
Mar 28

Lazard Asset Management Increases Stake in SINOPHARM by Approximately 2.1 Million Shares

Stock News
·
Mar 27

Sinopharm Group Stock Falls 3.6% in Hong Kong

Dow Jones
·
Mar 24

UBS Slightly Raises SINOPHARM (01099) Target Price to HK$25.7, Anticipates Stronger Revenue Growth This Year

Stock News
·
Mar 24

SINOPHARM Shares Drop Nearly 5% Following Annual Results; Citi Trims Target Price

Stock News
·
Mar 24

Sinopharm FY2025 net profit rose 3.94% to RMB 10,834 million as net cash from operating activities climbed 22.45% to RMB 14,138 million

Reuters
·
Mar 23

SINOPHARM Reports Annual Earnings with 1.5% Rise in Net Profit Attributable to Owners

Stock News
·
Mar 23

BRIEF-Sinopharm Group Posts FY Profit Attributable Of RMB7.16 BLN

Reuters
·
Mar 23

Sinopharm Group proposes final dividend of RMB 0.69 per share

Reuters
·
Mar 23

Sinopharm Group - FY Profit Attributable RMB7.16 Bln

THOMSON REUTERS
·
Mar 23

Sinopharm Group - Final Dividend of RMB0.69 per Ordinary Share Is to Be Proposed

THOMSON REUTERS
·
Mar 23

Sinopharm Group (SEHK:1099) Valuation Check As Recent Share Price Moves Draw Investor Attention

Simply Wall St.
·
Mar 20

SINOPHARM Subsidiary Reports Annual Operating Profit of RMB 1.25 Billion, Up 2.38%

Stock News
·
Mar 19

Sinopharm subsidiary CNMDC posts RMB 74.89 billion 2025 revenue and RMB 506.76 million comprehensive income attributable to parent owners

Reuters
·
Mar 19

OSR subsidiary Woori IO signs NDA with Sinopharm to explore China opportunities

Reuters
·
Mar 19